Genenta Science S p A : Consolidated Statements of Operation

Genenta Science S p A : Consolidated Statements of Operations and Comprehensive Loss - Form 6-K -October 20, 2023 at 04:55 pm EDT

Genenta Science S.p.A.


Consolidated Statements of Operations and Comprehensive Loss








Six Months Ended June...

Related Keywords

Russia , United States , Delaware , Milan , Lombardia , Italy , Bresso , Ukraine , America , Italian , Bernhard Gentner , Richard Slansky , Carlo Russo , Imposta Sul Valore Aggiunto , Institut Pasteur , Pierluigi Paracchi , Raffaele Hospitalas , Bernard Rudolph Gentner , Luigi Naldini , Manufacturing Service Agreement , Company Of Theravecty , Master Service Agreement , Head Of Development , Company Board Of Directors The , Framework Service Agreement , Company Equity Incentive Plan , Glaxosmithkline Intellectual Property Development , European Commission , International Accounting Standards , Cantor Fitzgerald Co , Company Is Euros , Research Agreementon , Exchange Commission , Genenta Science Inc , Company At , Company Annual , Nasdaq , Research Agreement , Company Consolidated Statements Of Operations , Company Annual Report On Form , Company Or Genenta , Investment Company , Months Ended June , Consolidated Financial , San Raffaele Hospital , Genenta Science , Nasdaq Stock Capital Market , Depository Shares , Controlled Equity , Cantor Fitzgerald , Sales Agreement , Renal Cell Cancer , Investment Company Act , Regulations X , Accounting Standards Codification , Accounting Standards Update , Financial Accounting Standards Board , Annual Report , Equity Incentive Plan , Consolidated Statements , Jumpstart Our Business Startups Act , Government Grants , Incentive Plan , Consolidated Statement , Comprehensive Loss , Income Taxes , Government Assistance , Business Entities , Own Equity , Convertible Instruments , Related Parties , Valore Aggiunto , Fine Rapporto , Consumer Price Index , Benefits The , Black Scholes , Average Remaining Contractual Term , Raffaele Hospital , Rudolph Gentner , Chief Medical Officer , Chief Financial Officer , San Raffaele , Chief Executive Officer , Scientific Advisory Board , License Agreement , Law Decree , Italian Golden Power , Adoption Fee , Royalty Term , Side Letter , Process Transfer Agreement , Tech Transfer , Research Agreementon August , Sponsored Research Agreement , Candidate Products , Markets ,

© 2025 Vimarsana